Advances in Interventional Cardiology
eISSN: 1897-4295
ISSN: 1734-9338
Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej
Current Issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
1/2026
vol. 22
 
Share:
Share:
Original paper

Predictors of major adverse cardiac events, high radiation exposure, and contrast use in percutaneous coronary interventions for calcified lesions

Christos N. Bousis
1
,
Evaggelia Kalampoki
2
,
Anna Kotsia
2
,
Pavlos Karanikis
2
,
Athanasios Kosovitsas
2
,
Eleni Tzima
2
,
Vasiliki Beli
2
,
Evgenia Pappa
2

  1. Medical Physics Department, General Hospital of Ioannina “CHATZIKOSTA”, Ioannina, Greece
  2. Cardiology Clinic, Haemodynamics Department, General Hospital of Ioannina “CHATZIKOSTA”, Ioannina, Greece
Adv Interv Cardiol 2026; 22, 1 (83): 8–20
Online publish date: 2026/03/09
Article file
- Predictors of major.pdf  [0.19 MB]
Get citation
 
 
1. Genereux P, Madhavan MV, Mintz GS, et al. Ischemic outcomes after coronary intervention of calcified vessels in acute coronary syndromes. Pooled analysis from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) and ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) TRIALS. J Am Coll Cardiol 2014; 63: 1845-54.
2. Fujita T, Takeda T, Hano Y, et al. Post-intervention minimal stent area as a predictor of target lesion revascularization after everolimus-eluting stent implantation for in-stent restenosis: a single-center observational study. Coron Artery Dis 2019; 30: 432-39.
3. Camilleri W, Kakar H, Elscot JJ, et al. Impact of coronary calcification on complete revascularization in patients with acute coronary syndrome and multivessel disease. Catheter Cardiovasc Interv 2025; 105: 1646-55.
4. Tseng YT, Yu YC, Cheng IN, et al. Percutaneous coronary intervention-related radiation ulcer: diagnosis, management, and prevention strategy. Acta Cardiol Sin 2023; 39: 480-7.
5. Ho TL, Shieh SH, Lin CL, et al. Risk of cancer among cardiologists who frequently perform percutaneous coronary interventions: a population-based study. Eur J Clin Invest 2016; 46: 527-34.
6. Rear R, Bell RM, Hausenloy DJ. Contrast-induced nephropathy following angiography and cardiac interventions. Heart 2016; 102: 638-48.
7. Jarvinen H, Farah J, Siiskonen T, et al. Feasibility of setting up generic alert levels for maximum skin dose in fluoroscopically guided procedures. Phys Med 2018; 46: 67-74.
8. Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 2004; 44: 1393-9.
9. Subban V, Amelot S, Victor SM, et al. Radiation doses during cardiac catheterisation procedures in India: a multicentre study. Asia Intervention 2020; 6: 25-33.
10. Bousis C, Kosovitsas T, Karanikis P, et al. Dose-area product reduction through a practice implementing low frame rate fluoroscopy and increased collimation during single-vessel percutaneous coronary interventions. Radiat Prot Environ 2024; 47: 121-8.
11. Sarkozy A, De Potter T, Heidbuchel H, et al. ESC Scientific Document Group. Occupational radiation exposure in the electrophysiology laboratory with a focus on personnel with reproductive potential and during pregnancy: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS). Europace 2017; 19: 1909-22. Erratum in: Europace 2018; 20: 574.
12. Riley RF, Patel MP, Abbott JD, et al. SCAI Expert Consensus Statement on the management of calcified coronary lesions. J Soc Cardiovasc Angiogr Interv 2024; 3: 101259.
13. Mintz GS, Popma JJ, Pichard AD, et al. Patterns of calcification in coronary artery disease. Circulation 1995; 91: 1959-65.
14. Siiskonen T, Ciraj-Bjelac O, Dabin J, et al. Establishing the European diagnostic reference levels for interventional cardiology. Phys Med 2018; 54: 42-8.
15. Georges JL, Livarek B, Gibault-Genty G, et al. Reduction of radiation delivered to patients undergoing invasive coronary procedures. Effect of a programme for dose reduction based on radiation-protection training. Arch Cardiovasc Dis 2009; 102: 821-7.
16. Koh Y, Vogrin S, Noaman S, et al. Effect of different anthropometric body indexes on radiation exposure in patients undergoing cardiac catheterisation and percutaneous coronary intervention. Tomography 2022; 8: 2256-67.
17. Christakopoulos GE, Christopoulos G, Karmpaliotis D, et al. Predictors of excess patient radiation exposure during chronic total occlusion coronary intervention: insights from a contemporary multicentre registry. Can J Cardiol 2017; 33: 478-84.
18. Steigen TK, Maeng M, Wiseth R, et al. Randomized study on simple versus complex stenting of coronary artery bifurcation lesions: the Nordic bifurcation study. Circulation 2006; 114: 1955-61.
19. Hosseini ZS, Jamili M, Ensan B, et al. Short-term effects of empagliflozin on preventing contrast induced acute kidney injury in patients undergoing percutaneous coronary intervention, a randomised trial. Sci Rep 2025; 15: 3940.
20. Meregildo-Rodriguez ED, Asmat-Rubio MG, Vásquez-Tirado GA. SGLT-2 inhibitors and prevention of contrast-induced nephropathy in patients with diabetes undergoing coronary angiography and percutaneous coronary interventions: systematic review and meta-analysis. Front Endocrinol (Lausanne) 2023; 14: 1307715.
21. Feitosa MPM, Lima EG, Abizaid AAC, et al. The safety of SGLT-2 inhibitors in diabetic patients submitted to elective percutaneous coronary intervention regarding kidney function: SAFE-PCI pilot study. Diabetol Metab Syndr 2023; 15: 138.
22. Peng JR, Chang CJ, Wang CL, et al. Impact of chronic kidney disease on long-term outcome in coronary bypass candidates treated with percutaneous coronary intervention. Korean Circ J 2017; 47: 50-5.
23. Coyle M, Flaherty G, Jennings C. A critical review of chronic kidney disease as a risk factor for coronary artery disease. Int J Cardiol Heart Vasc 2021; 35: 100822.
24. Lee JM, Choi KH, Song YB, et al. Intravascular imaging-guided or angiography-guided complex PCI. N Engl J Med 2023; 388: 1668-79.
25. Kitasato L, Shimohama T, Ikeda Y, et al. Clinical outcomes of chronic kidney disease patients treated with everolimus-eluting stents (EES) and paclitaxel-eluting stents (PES). Biomed Pharmacother 2015; 72: 6-10.
26. Sharma SK, Bolduan RW, Patel MR, et al. Impact of calcification on percutaneous coronary intervention: MACE-Trial 1-year results. Catheter Cardiovasc Interv 2019; 94: 187-94.
27. Moghadam AS, Kakavand N, Shirmard FO, et al. Intravascular lithotripsy versus rotational atherectomy in the management of calcific coronary lesions: a systematic review and meta-analysis. Catheter Cardiovasc Interv 2025; 106: 1142-52.
28. Khalefa BB, Ayyad M, Alqeeq BF, et al. Rotational atherectomy followed by modified (cutting or scoring) balloon versus plain balloon before drug‑eluting stent implantation for calcified coronary lesions: a meta-analysis. Catheter Cardiovasc Interv 2025; 105: 909-26.
29. Błaszkiewicz M, Florek K, Zimoch W, et al. Predictors of periprocedural myocardial infarction after rotational atherectomy. Adv Interv Cardiol 2024; 20: 62-6.
Copyright: © 2026 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.

Quick links
© 2026 Termedia Sp. z o.o.
Developed by Termedia.